EFFECTS OF SELEGILINE DOSING ON MOTOR FLUCTUATIONS IN PARKINSONS-DISEASE

被引：21

作者：

HUBBLE, JP ^{[1
]}

KOLLER, WC ^{[1
]}

WATERS, C ^{[1
]}

机构：

[1] UNIV SO CALIF,DEPT NEUROL,LOS ANGELES,CA 90089

来源：

CLINICAL NEUROPHARMACOLOGY | 1993年 / 16卷 / 01期

关键词：

SELEGILINE; DEPRENYL; PARKINSON DISEASE; MOTOR FLUCTUATION;

D O I：

10.1097/00002826-199302000-00010

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

To examine selegiline's dosing effects, we studied 16 Parkinson disease patients with motor fluctuations in a double-blind, crossover trial of selegiline at 0, 5, and 10 mg daily. Patients' motor diaries, disability scores, and walking speed were marginally improved, with no advantage of 10 mg over 5 mg found. We conclude that in patients with motor fluctuations, selegiline provides modest symptomatic effects, with daily dosing of 5 mg being indistinguishable from 10 mg.

引用

页码：83 / 87

页数：5

共 50 条

[21] NEUROPROTECTION BY ANTIOXIDANT STRATEGIES IN PARKINSONS-DISEASE
LEWITT, PA
EUROPEAN NEUROLOGY, 1993, 33 : 24 - 30
[22] THE PHARMACOLOGY OF PARKINSONS-DISEASE THERAPY - AN UPDATE
KOPIN, IJ
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1993, 33 : 467 - 495
[23] SPEECH DYSFUNCTION IN EARLY PARKINSONS-DISEASE
STEWART, C
WINFIELD, L
HUNT, A
BRESSMAN, SB
FAHN, S
BLITZER, A
BRIN, MF
MOVEMENT DISORDERS, 1995, 10 (05) : 562 - 565
[24] NIGRAL DEGENERATION IN PARKINSONS-DISEASE IN RELATION TO CLINICAL-FEATURES
RINNE, JO
ACTA NEUROLOGICA SCANDINAVICA, 1991, 84 : 87 - 90
[25] MULTICENTER STUDY OF SINEMET(R) CR (CARBIDOPALEVODOPA-50/200) IN PARKINSONS-DISEASE WITH AND WITHOUT FLUCTUATIONS
ZIEGLER, M
SEMAINE DES HOPITAUX, 1994, 70 (23-24): : 696 - 704
[26] MONOAMINE-OXIDASE, DOPAMINE AND PARKINSONS-DISEASE
ORELAND, L
ACTA NEUROLOGICA SCANDINAVICA, 1991, 84 : 60 - 65
[27] PARKINSONS-DISEASE - NEW APPROACHES TO DIAGNOSIS AND TREATMENT
YAHR, MD
ACTA NEUROLOGICA SCANDINAVICA, 1993, 87 : 22 - 25
[28] SELEGILINE PROTECTS DOPAMINERGIC-NEURONS IN CULTURE FROM TOXIC FACTOR(S) PRESENT IN THE CEREBROSPINAL-FLUID OF PATIENTS WITH PARKINSONS-DISEASE
HAO, R
EBADI, M
PFEIFFER, RF
NEUROSCIENCE LETTERS, 1995, 200 (02) : 77 - 80
[29] NEW STRATEGIES IN THE TREATMENT OF EARLY PARKINSONS-DISEASE
RINNE, UK
ACTA NEUROLOGICA SCANDINAVICA, 1991, 84 : 95 - 98
[30] DELAYED DEVELOPMENT OF SYMPTOMATIC IMPROVEMENT BY (-)-DEPRENYL IN PARKINSONS-DISEASE
MALLY, J
KOVACS, AB
STONE, TW
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1995, 134 (1-2) : 143 - 145

← 1 2 3 4 5 →